Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina . Atherosclerosis , Volume 180 , Issue 2 , Pages 399 - 405 C . Van Hove , F . Carreer-Bruhwyler , J . Géczy , A . Herman
Update My Preferred Elsevier Websites